CTRI/2017/06/008799已完成2 期
An Open Label, Multi-center, Prospective, Interventional, Clinical Study to Evaluate Efficacy and Safety of Ayuvigo Forte Capsules in Patients Suffering From Oligospermia - NI
Welex Laboratories Pvt Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Sperm concentration less than 15 million per ml (WHO laboratory manual for the examination and processing of human semen, Fifth Edition, 2010) with normal sperm morphology, with or without sperm total motility less than 40 percent or sperm forward progressive motility less than 32 percent.
- •2. Subjects should be in an active stable sexual relationship for the duration of study
- •3. Subjects who are willing to give informed consent and ready to comply with the protocol
- •4. Subjects who are ready to provide regular follow ups till the completion of the study
排除标准
- •1. Subjects with major illnesses and sexual dysfunction due to anatomical, surgical or pharmacological causes
- •2. Subjects with total erectile failure or any other sexual disorder
- •3. Subjects with history of central nervous system disorders such as stroke, transient ischemic attacks or spinal cord injury or pelvic surgery
- •4. Subjects with hypotension or uncontrolled hypertension, uncontrolled diabetes, hepatic impairment, renal impairment or hematological disorders
- •5. Subjects with clinical symptoms of scrotal varicocele and confirmed with USG and colour Doppler will be excluded from the study
- •6. Subjects with significant abnormal laboratory parameters
研究者
相似试验
进行中（未招募）
不适用
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease.EUCTR2012-002066-12-ATOVAGALI Pharma S.A.S130
进行中（未招募）
不适用
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease.Severe Dry Eye DiseaseMedDRA version: 14.1Level: LLTClassification code 10023350Term: Keratoconjunctivitis siccaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10013778Term: Dry eyesSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10013777Term: Dry eye syndromeSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10013774Term: Dry eyeSystem Organ Class: 10015919 - Eye disordersEUCTR2012-002066-12-GBOVAGALI Pharma S.A.S130
进行中（未招募）
不适用
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease.EUCTR2012-002066-12-BEOVAGALI Pharma S.A.S130
进行中（未招募）
不适用
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease.EUCTR2012-002066-12-DEOVAGALI Pharma S.A.S125
进行中（未招募）
1 期
One cohort Study To Assess the duration of the improvement following NOVA22007 Treatment Discontinuation in Improved Patients With Severe Dry Eye Disease.EUCTR2012-002066-12-CZOVAGALI Pharma S.A.S130